Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Hemorrhagic Shock, Trauma Injury

In brief

The MATIC-2 is a multicenter clinical trial enrolling children who are less than 18 years of age with hemorrhagic shock potentially needing significant blood transfusion. The primary objective of the clinical trial is to determine the effectiveness of Low Titer Group O Whole Blood (LTOWB) compared to component therapy (CT), and Tranexamic Acid (TXA) compared to placebo in decreasing 24-hour all-cause mortality in children with traumatic life threatening hemorrhage.

Key facts

Study ID
NCT06070350
Run by
Philip Spinella
People needed
1000
Starts
2024-11-01
Expected to finish
2028-10-01
Last updated by the study team
2026-07-21

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.